Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Pharmacol ; 897: 173949, 2021 Apr 15.
Article in English | MEDLINE | ID: mdl-33607108

ABSTRACT

Schizophrenia is a devastating neurodevelopmental disorder. The animal model based on perinatal immune activation, as first-hit, combined with peripubertal stress, as a second hit, has gained evidence in recent years. Omega-3 polyunsaturated fatty acids (n3-PUFAs) is being a promise for schizophrenia prevention. Nevertheless, the influence of sex in schizophrenia neurobiology and prevention has been neglected. Thus, the present study evaluates the preventive effects of n3-PUFAs in both sexes' mice submitted to the two-hit model and the participation of oxidative changes in this mechanism. The two-hit consisted of polyI:C administration from postnatal days (PNs) 5-7, and unpredictable stress from PNs35-43. n3-PUFAs were administered from PNs30-60. Prepulse inhibition of the startle reflex (PPI), social interaction, and Y-maze tests were conducted between PNs70-72 to evaluate positive-, negative-, and cognitive-like schizophrenia symptoms. We assessed brain oxidative changes in brain areas and plasma. Both sexes' two-hit mice presented deficits in PPI, social interaction, and working memory that were prevented by n3-PUFAs. In two-hit females, n3-PUFAs prevented increments in nitrite levels in the prefrontal cortex (PFC), hippocampus, striatum, and plasma TBARS levels. In two-hit males, n3-PUFAs prevented the increase in TBARS in the PFC, hippocampus, and striatum. Notably, male mice that received only n3-PUFAs without hit exposure presented impairments in working memory and social interaction. These results add further preclinical evidence for n3-PUFAs as an accessible and effective alternative in preventing behavioral and oxidative changes related to schizophrenia but call attention to the need for precaution in this indication due to hit- and sex-sensitive issues.


Subject(s)
Antioxidants/pharmacology , Behavior, Animal/drug effects , Brain/drug effects , Fatty Acids, Omega-3/pharmacology , Oxidative Stress/drug effects , Schizophrenia/prevention & control , Schizophrenic Psychology , Age Factors , Animals , Brain/metabolism , Brain/physiopathology , Dietary Supplements , Disease Models, Animal , Female , Male , Maze Learning/drug effects , Mice , Poly I-C , Prepulse Inhibition/drug effects , Reflex, Startle/drug effects , Schizophrenia/etiology , Schizophrenia/metabolism , Schizophrenia/physiopathology , Sex Factors , Sexual Development , Social Behavior , Stress, Psychological/complications
SELECTION OF CITATIONS
SEARCH DETAIL
...